Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1

3 years ago

Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"),…

Dignio and AceAge Partner to Offer Karie Smart Pill Dispenser in Norway

3 years ago

Oslo, Norway--(Newsfile Corp. - February 3, 2022) - Dignio AS, Norway's leading provider of digital remote care to Home Care…

Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care

3 years ago

Leading Digital Health Company Expands Provider and Payer Customer Base as Demand for Patient Access Solutions Accelerates Across the Healthcare…

Baker Tilly Acquires Orchestrate Healthcare

3 years ago

Combination scales firm’s data and digital technology capabilities for healthcare providers WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Leading advisory CPA firm Baker…

Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

3 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

Millions of Siemens Healthineers CLINITEST Rapid COVID-19 Antigen Self-Test Now Available in the U.S.

3 years ago

The CLINITEST Rapid COVID-19 Antigen Self-Test recently received FDA Emergency Use Authorization. The test is available and already supporting COVID-19…

UK Scaleup Navenio Hires New CEO To Drive US Expansion Following 153% Growth in 2021

3 years ago

Navenio strengthens senior team with the appointment of a new CEO to build out its global offering, after securing first…

Vimian Group Acquires Supplier of Veterinary Surgical Products in New Zealand and Australia

3 years ago

STOCKHOLM, SE / ACCESSWIRE / February 3, 2022 / Vimian Group (STO:VIMIAN)Vimian Group has today signed an agreement to acquire…

Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program

3 years ago

ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in…

Apollon Formularies plc Announces Grand Opening of International Cancer Institute

3 years ago

Grand Opening of International Cancer and Chronic Pain InstituteLONDON, UK / ACCESSWIRE / February 3, 2022 / Apollon Formularies plc…